Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TPMT | P51580 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.34 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18050251 | 1.00 | KDM4E (0.44) | KDM4EL3MBTL1ELANEHTTMAPT | |
| SCHEMBL18050353 | 0.81 | ALDH1A1 (0.40) | KDM4EL3MBTL1ELANEHPGDPOLB | |
| SCHEMBL18050356 | 0.81 | ALDH1A1 (0.40) | KDM4EL3MBTL1ELANEHPGDPOLB | |
| SCHEMBL13543176 | 0.73 | KDM4E (0.46) | KDM4EL3MBTL1ELANEHTTMAPT | |
| SCHEMBL18050320 | 0.71 | ALDH1A1 (0.50) | ELANEHTTMAPTNPSR1HPGD | |
| SCHEMBL18050319 | 0.71 | ALDH1A1 (0.50) | ELANEHTTMAPTNPSR1HPGD | |
| SCHEMBL18050255 | 0.70 | TDP1 (0.50) | MAPTNPSR1CYP2C9HPGDLMNA | |
| SCHEMBL18050257 | 0.70 | TDP1 (0.50) | MAPTNPSR1CYP2C9HPGDLMNA | |
| SCHEMBL248738 | 0.70 | CYP3A4 (0.41) | KDM4EL3MBTL1MAPTTPMTTAS1R3 | |
| SCHEMBL377596 | 0.69 | KDM4E (0.55) | KDM4EL3MBTL1MAPTTPMTTAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3268398-B1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA SRL (IT) | 2019-05-15 | — | — | EP | disclosed |
| US-10246532-B2 | Catalyst components for the polymerization of olefins | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2019-04-02 | — | — | US | disclosed |
| US-20180051106-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2018-02-22 | — | — | US | disclosed |
| EP-3268398-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.r.l. (IT) | 2018-01-17 | — | — | EP | disclosed |
| WO-2016142377-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2016-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180051106-A1 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | C1S, CCNT1, COG1 | KDM4E 4584/4885L3MBTL1 1834/4885ELANE 3704/4885 |
| US-10246532-B2 | Catalyst components for the polymerization of olefins | C1S, CCNT1, COG1 | KDM4E 4584/4885L3MBTL1 1834/4885ELANE 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.